Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Contineum Therapeutics, Inc. | 710,494 | reported | 09 Apr 2024 | tx 21+5,483,756 |
| Repare Therapeutics Inc. | 25,587 | reported | 06 Jun 2022 | tx 83+6,714,413−9,316,484 |
| Oyster Point Pharma, Inc. | 2,465 | reported | 05 Jan 2022 | tx 9+63,663−590,137 |
| Black Diamond Therapeutics, Inc. | 307 | reported | 14 Dec 2020 | tx 19+617−200,401 |
| LAVA Therapeutics NV | 0 | reported | 19 Sept 2025 | tx 2−2,903,403 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 Sept 2025 | SALE | LAVA Therapeutics NV | 2,370,533 | 1.40 USD | |
| 19 Sept 2025 | SALE | LAVA Therapeutics NV | 532,870 | 1.40 USD | |
| 09 Apr 2024 | CONVERSION | Contineum Therapeutics, Inc. | 391,785 | — | |
| 09 Apr 2024 | CONVERSION | Contineum Therapeutics, Inc. | 148,312 | — | |
| 09 Apr 2024 | CONVERSION | Contineum Therapeutics, Inc. | 2,531 | — | |
| 09 Apr 2024 | CONVERSION | Contineum Therapeutics, Inc. | 90,747 | — | deriv |
| 09 Apr 2024 | CONVERSION | Contineum Therapeutics, Inc. | 22,312 | — | deriv |
| 09 Apr 2024 | CONVERSION | Contineum Therapeutics, Inc. | 145 | — | deriv |
| 09 Apr 2024 | CONVERSION | Contineum Therapeutics, Inc. | 57,565 | — | deriv |
| 09 Apr 2024 | CONVERSION | Contineum Therapeutics, Inc. | 1,476,446 | — | deriv |
| 09 Apr 2024 | CONVERSION | Contineum Therapeutics, Inc. | 9,252 | — | deriv |
| 09 Apr 2024 | CONVERSION | Contineum Therapeutics, Inc. | 1,423,119 | — | deriv |
| 09 Apr 2024 | CONVERSION | Contineum Therapeutics, Inc. | 348,143 | — | deriv |
| 09 Apr 2024 | CONVERSION | Contineum Therapeutics, Inc. | 2,182 | — | deriv |
| 09 Apr 2024 | CONVERSION | Contineum Therapeutics, Inc. | 434,725 | — | deriv |
| 09 Apr 2024 | CONVERSION | Contineum Therapeutics, Inc. | 317,988 | — | deriv |
| 09 Apr 2024 | CONVERSION | Contineum Therapeutics, Inc. | 110,187 | — | deriv |
| 09 Apr 2024 | CONVERSION | Contineum Therapeutics, Inc. | 689 | — | deriv |
| 09 Apr 2024 | CONVERSION | Contineum Therapeutics, Inc. | 275,769 | — | deriv |
| 09 Apr 2024 | CONVERSION | Contineum Therapeutics, Inc. | 1,931 | — | deriv |
| 09 Apr 2024 | CONVERSION | Contineum Therapeutics, Inc. | 298,975 | — | deriv |
| 09 Apr 2024 | CONVERSION | Contineum Therapeutics, Inc. | 70,498 | — | deriv |
| 09 Apr 2024 | CONVERSION | Contineum Therapeutics, Inc. | 455 | — | deriv |
| 06 Jun 2022 | OTHER | Repare Therapeutics Inc. | 132,692 | 0.00 USD | |
| 06 Jun 2022 | OTHER | Repare Therapeutics Inc. | 46,753 | 0.00 USD |